Recombinant bovine pancreatic trypsin inhibitor protects the liver from carbon tetrachloride-induced chronic injury in rats

References

• Aibiki M, Cook JA. (1997). Ulinastatin, a human trypsin inhibitor, inhibits endotoxin-induced thromboxane B2 production in human monocytes. Crit Care Med 25:430–44
   PubMed Web of Science ®Google Scholar
• Andus T, Bauer J, Gerok W. (1991). Effects of cytokines on the liver. Hepatology 13:364–75
   PubMed Web of Science ®Google Scholar
• Antuch W, Berndt KD, Chávez MA, et al. (1993). The NMR solution structure of a Kunitz-type proteinase inhibitor from the sea anemone Stichodactyla helianthus. Eur J Biochem 212:675–84
   PubMedGoogle Scholar
• Barbar E, Hare M, Makokha M, et al. (2001). NMR-detected order in core residues of denatured bovine pancreatic trypsin inhibitor. Biochemistry 40:9734–42
   PubMedGoogle Scholar
• Bull DA, Connors RC, Albanil A, et al. (2000). Aprotinin preserves myocardial biochemical function during cold storage through suppression of tumor necrosis factor. J Thorac Cardiovasc Surg 119:242–50
   PubMedGoogle Scholar
• Englberger L, Kipfer B, Berdat PA, et al. (2002). Aprotinin in coronary operation with cardiopulmonary bypass: Does “low-dose” aprotinin inhibit the inflammatory response? Ann Thorac Surg 73:1897–904
   PubMed Web of Science ®Google Scholar
• Frei A, Zimmermann A, Weigand K. (1984). The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease. Hepatology 4:830–4
   PubMed Web of Science ®Google Scholar
• Hagihara Y, Shiraki K, Nakamura T, et al. (2002). Screening for stable mutants with amino acid pairs substituted for the disulfide bond between residues 14 and 38 of bovine pancreatic trypsin inhibitor (BPTI). J Biol Chem 277:51043–8
   PubMedGoogle Scholar
• Inoue K, Takano H, Shimada A, et al. (2005a). Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide. Mol Pharmacol 67:673–80
   PubMed Web of Science ®Google Scholar
• Inoue K, Takano H, Yanagisawa R, et al. (2005b). Protective role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide. Exp Biol Med (Maywood) 230:281–7
   PubMed Web of Science ®Google Scholar
• Korabiowska M, Schlott T, Siems N, et al. (2004). Analysis of adenomatous polyposis coli gene expression, APC locus-microsatellite instability and APC promoter methylation in the progression of melanocytic tumours. Mod Pathol 17:1539–44
   PubMedGoogle Scholar
• Laxenaire MC, Dewachter P, Pecquet C. (2000). Allergic risk of aprotinin. Ann Fr Anesth Reanim 19:96–104
   PubMedGoogle Scholar
• Molenaar IQ, Begliomini B, Grazi GL, et al. (2001). The effect of aprotinin on renal function in orthotopic liver transplantation. Transplantation 71:247–52
   PubMed Web of Science ®Google Scholar
• Mojcik CF, Levy JH. (2001). Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg 71:745–54
   PubMed Web of Science ®Google Scholar
• Mycek MA, Schomacker KT, Nishioka NS. (1998). Colonic polyp differentiation using time-resolved autofluorescence spectroscopy. Gastrointest Endosc 48:390–4
   PubMedGoogle Scholar
• Ohta Y, Sahashi D. (2002). .-Tryptophan administration promotes the reversion of pre-established chronic liver injury in rats treated with carbon tetrachloride. J Nutr Biochem 13:550
   PubMedGoogle Scholar
• Pritchard L, Dufton MJ. (1999). Evolutionary trace analysis of the Kunitz/BPTI family of proteins: Functional divergence may have been based on conformational adjustment. J Mol Biol 285:1589–607
   PubMedGoogle Scholar
• Raghow R, Postlethwaite AE, Keski-Oja J, et al. (1987). Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest 79:1285–8
   PubMed Web of Science ®Google Scholar
• Roberts AB, Anzano MA, Wakefield LM, et al. (1985). Type beta transforming growth factor: A bifunctional regulator of cellular growth. Proc Natl Acad Sci USA 82:119–223
   PubMed Web of Science ®Google Scholar
• Sarban S, Kocyigit A, Yazar M, Isikan UE. (2005). Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 38:981–6
   PubMed Web of Science ®Google Scholar
• Schmartz D, Tabardel Y, Preiser JC, et al. (2003). Does aprotinin influence the inflammatory response to cardiopulmonary bypass in patients? J Thorac Cardiovasc Surg 125:184–90
   PubMedGoogle Scholar
• Tassani P, Augustin N, Barankay A, et al. (2000). High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 14:682–6
   PubMedGoogle Scholar
• Varga J, Jimenez SA. (1986). Stimulation of normal human fibroblast collagen production and processing by transforming growth factor-beta. Biochem Biophys Res Commun 138:974–80
   PubMed Web of Science ®Google Scholar
• Yang L, Dong W, He J, et al. (2008). Expression and purification of natural N-terminal recombinant bovine pancreatic trypsin inhibitor from Pichia pastoris. Biol Pharm Bull 31:1680–5
   PubMedGoogle Scholar
• Yang L, Dong W, Yan F, et al. (2010). Recombinant bovine pancreatic trypsin inhibitor protects the liver from carbon tetrachloride-induced acute injury in mice. J Pharm Pharmacol 62:332–8
   PubMed Web of Science ®Google Scholar